
|Articles|February 1, 2011
- Pharmaceutical Executive-02-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - February 2011
The Promise Of Translational Medicine
Advertisement
Articles in this issue
over 15 years ago
Skipping the Needle: Pharm Exec's Brand of the Yearover 15 years ago
Honing Reforms from Clinical Developmentover 15 years ago
Growing Stronger After the StormAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5



